Metabolic and Antidiabetic Effects of Rosa damascena Mill. Extract in Animal Models of Diabetes Mellitus: A Systematic Review
DOI:
10.59888/ajosh.v4i11.768Published:
2026-08-12Downloads
Abstract
Diabetes mellitus is a chronic metabolic disorder affecting more than 537 million adults worldwide, with its prevalence in Indonesia projected to reach 16.09% by 2045. Rosa damascena Mill. contains bioactive compounds with antioxidant, anti-inflammatory, and antihyperglycemic properties; however, its antidiabetic potential has not been systematically reviewed. This systematic review aims to evaluate the metabolic and antidiabetic effects of Rosa damascena Mill. extract in animal models of diabetes mellitus. This review followed the PRISMA 2020 guidelines. A comprehensive literature search was conducted in PubMed, ScienceDirect, Web of Science, and ProQuest, identifying 504 records. Six in vivo animal studies met the inclusion criteria. Diabetes was induced using streptozotocin or a high-fructose diet in male Wistar rats. The risk of bias was assessed using the SYRCLE risk-of-bias tool, and reporting quality was evaluated using the ARRIVE Essential 10 guidelines. Findings were synthesised descriptively. Rosa damascena Mill. extract improved glycaemic and metabolic parameters, with a significant reduction in fasting blood glucose at a dose of 1000 mg/kg (p < 0.0001) and a consistent reduction in triglyceride levels (75 ± 9 vs. 217 ± 18 mg/dL). Methanolic extract demonstrated 98% a-glucosidase inhibition compared with 51% for acarbose. Improvements in insulin sensitivity, increased adiponectin levels, and reduced NF-kB expression were also observed, although changes in HbA1c were not statistically significant. Although Rosa damascena demonstrates promising antidiabetic effects, the available evidence remains limited due to the small number of studies (n = 6), methodological heterogeneity, and unclear risk of bias, highlighting the need for further standardised research.
Keywords:
diabetes mellitus rosa damascena herbal medicine antidiabetic effect fasting blood glucose levelReferences
Akmal, M., Patel, A., & Wadhwa, R. (2024). Alpha Glucosidase Inhibitors. StatPearls Publishing.
Ansari, P., Khan, J. T., Chowdhury, S., Reberio, A. D., Kumar, S., Seidel, V., Abdel-Wahab, Y. H. A., & Flatt, P. R. (2024). Plant-Based Diets and Phytochemicals in the Management of Diabetes Mellitus and Prevention of Its Complications: A Review. Nutrients, 16(21), 3709.
Aryaeian, N., Khorshidi Sedehi, S., & Arablou, T. (2017). Polyphenols and their effects on diabetes management: A review. Medical Journal of the Islamic Republic of Iran, 31, 134.
Boskabady, M. H., Shafei, M. N., Saberi, Z., & Amini, S. (2011). Pharmacological effects of Rosa damascena. Iranian Journal of Basic Medical Sciences, 14(4).
Cahyana, Y., & Adiyanti, T. (2021). Flavonoids as Antidiabetic Agents. Indonesian Journal of Chemistry, 21(2), 512.
Caturano, A., D’Angelo, M., Mormone, A., Russo, V., Mollica, M. P., Salvatore, T., et al. (2023). Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications. Current Issues in Molecular Biology, 45(8), 6651–6666.
Chandana, J. V. S., Kumar, G. A., & Vaishnavi, B. (2024). A Review on Antioxidant Activity of Rosa damascena. International Journal of Research and Review, 11(3), 156–162.
Choirotussanijjah, Notopuro, H., & Qurnianingsih, E. (2021). Effects of ethanol extract of Rosa damascena on HbA1c level and NF-?B expression in diabetic rats. Indonesian Journal of Medical Laboratory Science and Technology, 3(2), 146–157.
Dewi, L., Jauhar, T., & Wibowo, P. (2023). Hematological parameters in streptozotocin-induced diabetic rats and the effect of Rosa damascena Mill. extract. Bali Medical Journal, 12(3), 2743–2747.
Dirir, A. M., Daou, M., Yousef, A. F., & Yousef, L. F. (2022). A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes. Phytochemistry Reviews, 21, 1–27.
Freeman, A. M., Acevedo, L. A., & Pennings, N. (2023). Insulin Resistance. StatPearls Publishing.
Furman, B. L. (2021). Streptozotocin-Induced Diabetic Models in Mice and Rats. Current Protocols, 1(4).
Goyal, R., Jialal, I., & Singhal, M. (2023). Type 2 Diabetes. StatPearls Publishing.
Hooijmans, C. R., Rovers, M. M., de Vries, R. B., Leenaars, M., Ritskes-Hoitinga, M., & Langendam, M. W. (2014). SYRCLE’s risk of bias tool for animal studies. BMC Medical Research Methodology, 14, 43.
Hri?cu, L. D., et al. (2025). Systematic Review: Exploring Inter-Species Variability in Diabetes Mellitus for Translational Medicine. Life, 16(1), 64.
Inayatillah, B., Jauhar, T., Mastutik, G., & Rahniayu, A. (2021). Hypoglycemic effects of Rosa damascena Mill. ethanolic extract on blood glucose levels and diameter of Langerhans pancreatic islets. Indian Journal of Forensic Medicine and Toxicology, 15(2), 2133–2140.
Jauhar, T., Inayatillah, B., Rochmanti, M., & Basori, A. (2021). Hypolipidemic effects of Rosa damascena Mill. extract in streptozotocin-induced diabetic rats. Indian Journal of Forensic Medicine and Toxicology, 15(2), 1065–1070.
Khezerlou, A., Mohammadi, K., Abedini, A., Sani, M. A., & McClements, D. J. (2025). Phytochemicals and bioactive functional ingredients from Rosa damascena: from extraction to application in the food and healthcare sectors. Food Chemistry: X, 31, 103202.
Khoramipour, K., Chamari, K., Hekmatikar, A. A., et al. (2021). Adiponectin: Structure, Physiological Functions, Role in Diseases, and Effects of Nutrition. Nutrients, 13(4), 1180.
Koz?owska, A., & Nitsch-Osuch, A. (2024). Anthocyanins and Type 2 Diabetes: An Update of Human Study and Clinical Trial. Nutrients, 16(11), 1674.
Labban, L., & Thallaj, N. (2020). The medicinal and pharmacological properties of Damascene Rose (Rosa damascena): A review. International Journal of Herbal Medicine, 8(2), 33–37.
Leiwakabessy, G., Gondokesumo, M. E., & Wahjudi, M. (2021). Medicinal plants as potential antidiabetic agents.
Mahboubi, M. (2016). Rosa damascena as holy ancient herb with novel applications. Journal of Traditional and Complementary Medicine, 6(1), 10–16.
McGuinness, L. A., & Higgins, J. P. T. (2021). Risk-of-bias visualization (robvis): An R package and web application. Systematic Reviews.
Mobeen, A., Joshi, S., Fatima, F., et al. (2025). NF-?B signaling is the major inflammatory pathway for inducing insulin resistance. 3 Biotech, 15(2).
Mohammadi, A., Fallah, H., & Gholamhosseinian, A. (2017). Antihyperglycemic effect of Rosa damascena is mediated by PPAR-? gene expression in animal model of insulin resistance. Iranian Journal of Pharmaceutical Research, 16(3), 1080–1088.
Page, M. J., McKenzie, J. E., Bossuyt, P. M., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71.
Percie du Sert, N., Hurst, V., Ahluwalia, A., et al. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biology, 18(7), e3000410.
Shaheer, Akhtar, & Jallo. (2025). (Sesuai sitasi pada pembahasan mengenai hubungan adiponektin dengan HOMA-IR dan metabolisme lipid).
Sohrabi, C., et al. (2021). PRISMA 2020 statement and systematic review reporting.
Wahidin, et al. (2024). Proyeksi prevalensi diabetes mellitus di Indonesia.
License
Copyright (c) 2026 Abdul Aziz Bin Haji Abdul Hamid, Maftuchah Rochmanti, citrawati.dyah@fk.unair.ac.id
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
